Feifei Zhou
Beijing, Beijing Municipality, 100191, China
NCT Number: NCT04962256
Enhanced recovery after surgery (ERAS) strategy has been used in the patient management of different diseases. This study aims to evaluate the effectiveness of ERAS in the perioperative period of posterior approach of cervical spine operation among patients with CSM.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Beijing, Beijing Municipality, 100191, China
Enhanced recovery after surgery (ERAS) strategy has been used in the patient management of different diseases, but up to now, few effort has been done to evaluate the effectiveness of ERAS in patients perioperative management of cervical spine surgery. As a interdisciplinary cooperation system, either qualitative or quantitative method alone can not completely reflect the function of ERAS. Mixed model research (MMR) is a appropriate method to evaluate a complex system, but it has not been used in ERAS evaluation. This study aims to evaluate the effectiveness of ERAS in the perioperative period of posterior approach of cervical spine operation among patients with CSM using MMR, including the retrospective quantitative part and prospective qualitative part. In the retrospective part, we will collect the data of length of stay, VAS scores, mJOA scores and SF-36 scores to compare the difference between ERAS group and regular group. In the prospective part, we will collect the data from the focus group meetings and personal interviews of patients, to verify that ERAS has the ability to improve the postoperative outcomes, while maintain an equal surgical effect.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ERAS management includes 3 parts: (1) Preoperative analgesia and airway evaluation. (2) The protection and reconstruction of the musculo-ligamentous complex during the surgery, the safe intubation, and the local infiltration anesthesia during surgery. (3) Collar free, multimodal analgesia, airway management, and early recovery after surgery.
Time frame: Preoperation
Visual analogue scale before after surgery, 0 to 10 points, higher means severer the pain is.
Time frame: 3 months after surgery.
Visual analogue scale 3-month after surgery, 0 to 10 points, higher means severer the pain is.
Time frame: Admission to discharge, an average of 3 days
Length of stay
Time frame: Preoperation
Modified Japanese Orthopaedic Association score before surgery, -2 to 17 points, higher means better outcome.
Time frame: 3 months after surgery.
Modified Japanese Orthopaedic Association score 3-month after surgery, -2 to 17 points, higher means better outcome.
Time frame: Preoperation
36-Item Short Form Survey score before surgery, 0 to 100 points, higher means better outcome.
Time frame: 3 months after surgery
36-Item Short Form Survey score 3-month after surgery, 0 to 100 points, higher means better outcome.
Time frame: Admission to discharge, an average of 3 days
Focus group meetings by specialists, to discuss the effect of ERAS and the what improvements can be made.
Time frame: At 3-month follow-up
Personal interviews of patients at 3-month follow-up
Peking University Third Hospital
Other
The Application of Enhanced Recovery After Surgery (ERAS) During the Perioperative Period of Patients With Posterior Approach of Cervical Spine Operation: a Mixed Methods Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03695848
Cervical Myelopathy
Hong Kong
View Trial DetailsNCT02125981
Cervical Myelopathy
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT04545983
Bone Diseases, Cervical Myelopathy
Heerlen, Limburg, Netherlands
View Trial DetailsNCT04173923
Cervical Myelopathy
Busan, South Korea
View Trial Details